ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Abstract

Background: Allergic asthma is a prevalent respiratory disease that has a significant impact on human health. Isthmin-1 (ISM1) is an endogenous anti-inflammatory protein downregulated in asthmatic lungs, but its role in allergic asthma remains unexplored.

Aim: To investigate the role of ISM1 in allergic airway inflammation.

Methods: We investigated the impact of ISM1 deficiency on airway inflammation using a house dust mite (HDM)-induced allergic asthma model in ISM1^-/- mice. We intratracheally delivered rISM1 to rescue the effects of ISM1^-/- in HDM-challenged mice. Molecular cell biology techniques were used to elucidate the underlying mechanisms.

Results: ISM1 functions to restrain airway hyperresponsiveness in allergic asthma in mice. ISM1^-/- mice showed an apparent worsening of allergic airway inflammation and hyperresponsiveness, accompanied by an increased HDM-specific IgE. The heightened inflammation in ISM1^-/- mice correlated with enhanced lung cell necroptosis, as indicated by higher pMLKL expression. Intratracheal delivery of rISM1 significantly reduced eosinophil number in BALF. Mechanistically, ISM1 stimulates adiponectin secretion by type 2 alveolar epithelial cells through the GRP78 receptor and enhances adiponectin-facilitated apoptotic cell clearance via alveolar macrophage efferocytosis. Reduced adiponectin expression under ISM1 deficiency also contributed to intensified necroptosis, prolonged inflammation, and heightened severity of airway hyperresponsiveness.

Conclusions: ISM1 downregulation in asthmatic lungs contributes to the progression of allergic asthma. Local airway-delivered rISM1 has therapeutic potential against allergic asthma and warrants further investigation.

Abstract

#{title}